133 related articles for article (PubMed ID: 22919317)
1. The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients.
Lazzeri S; Orlandi P; Figus M; Fioravanti A; Cascio E; Di Desidero T; Agosta E; Canu B; Sartini MS; Danesi R; Nardi M; Bocci G
ScientificWorldJournal; 2012; 2012():420190. PubMed ID: 22919317
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
[TBL] [Abstract][Full Text] [Related]
3. VEGF A (rs699947 and rs833061) and VEGFR2 (rs2071559) gene polymorphisms are not associated with AMD susceptibility in a Spanish population.
Cruz-González F; Cieza-Borrella C; Cabrillo-Estévez L; Cañete-Campos C; Escudero-Domínguez F; González-Sarmiento R
Curr Eye Res; 2013 Dec; 38(12):1274-7. PubMed ID: 23971975
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration.
Fang AM; Lee AY; Kulkarni M; Osborn MP; Brantley MA
Mol Vis; 2009 Dec; 15():2710-9. PubMed ID: 20019880
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
García M; Álvarez L; Fernández Á; González-Iglesias H; Escribano J; Fernández-Vega B; Villota E; Fernández-Vega Cueto L; Fernández-Vega Á; Coca-Prados M
Ophthalmic Genet; 2017; 38(5):451-458. PubMed ID: 28635422
[TBL] [Abstract][Full Text] [Related]
6. IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration.
Lazzeri S; Orlandi P; Piaggi P; Sartini MS; Casini G; Guidi G; Figus M; Fioravanti A; Di Desidero T; Ripandelli G; Parravano M; Varano M; Nardi M; Bocci G
Pharmacogenomics; 2016; 17(1):35-9. PubMed ID: 26653034
[TBL] [Abstract][Full Text] [Related]
7. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
[TBL] [Abstract][Full Text] [Related]
8. Genes in the high-density lipoprotein metabolic pathway in age-related macular degeneration and polypoidal choroidal vasculopathy.
Liu K; Chen LJ; Lai TY; Tam PO; Ho M; Chiang SW; Liu DT; Young AL; Yang Z; Pang CP
Ophthalmology; 2014 Apr; 121(4):911-6. PubMed ID: 24393350
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration.
Sharma NK; Gupta A; Prabhakar S; Singh R; Sharma S; Anand A
Curr Neurovasc Res; 2012 Nov; 9(4):256-65. PubMed ID: 23030506
[TBL] [Abstract][Full Text] [Related]
10. Investigation of genetic base in the treatment of age-related macular degeneration.
Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K
Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
[TBL] [Abstract][Full Text] [Related]
11. Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter.
Molinaro A; Orlandi P; Niccolai F; Agretti P; De Marco G; Ferrarini E; Di Cosmo C; Vitti P; Piaggi P; Di Desidero T; Bocci G; Tonacchera M
J Endocrinol Invest; 2020 Feb; 43(2):149-155. PubMed ID: 31376092
[TBL] [Abstract][Full Text] [Related]
12. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
Oszajca K; Szemraj M; Szemraj J; Jurowski P
Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
[TBL] [Abstract][Full Text] [Related]
13. CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
García M; Álvarez L; Nogacka AM; González-Iglesias H; Escribano J; Fernández-Vega B; Fernández-Vega Á; Fernández-Vega L; Coca-Prados M
Acta Ophthalmol; 2015 Dec; 93(8):e658-66. PubMed ID: 26152901
[TBL] [Abstract][Full Text] [Related]
14. HIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age-related macular degeneration?
Okur V; Cetin O; Cetin E; Tepeli E; Bulgu Y; Yildirim C
Clin Exp Ophthalmol; 2015; 43(1):47-53. PubMed ID: 24995509
[TBL] [Abstract][Full Text] [Related]
15. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI
Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423
[TBL] [Abstract][Full Text] [Related]
16. The genetic variant rs4073 A→T of the Interleukin-8 promoter region is associated with the earlier onset of exudative age-related macular degeneration.
Hautamäki A; Seitsonen S; Holopainen JM; Moilanen JA; Kivioja J; Onkamo P; Järvelä I; Immonen I
Acta Ophthalmol; 2015 Dec; 93(8):726-33. PubMed ID: 26154559
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M
Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788
[TBL] [Abstract][Full Text] [Related]
18. Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
Wang VM; Rosen RB; Meyerle CB; Kurup SK; Ardeljan D; Agron E; Tai K; Pomykala M; Chew EY; Chan CC; Tuo J
Mol Vis; 2012; 18():2578-85. PubMed ID: 23112570
[TBL] [Abstract][Full Text] [Related]
19. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.
McKibbin M; Ali M; Bansal S; Baxter PD; West K; Williams G; Cassidy F; Inglehearn CF
Br J Ophthalmol; 2012 Feb; 96(2):208-12. PubMed ID: 21558292
[TBL] [Abstract][Full Text] [Related]
20. Association and interaction effect between VEGF receptor-2 (VEGFR-2) gene polymorphisms and dietary pattern on blood uric acid in Malays and Indians.
Roseline YW; Shidoji Y; Hon WM; Masaki M
Malays J Nutr; 2012 Dec; 18(3):307-17. PubMed ID: 24568071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
